Front Page News
House of Representatives Passes Ensuring Access to Clinical Trials Act
The House of Representatives has passed the Ensuring Access to Clinical Trials Act of 2015 (EACT). This bill already passed the Senate in July, and […]
Read More ›Thank You to Jessica Moyer and Family
A note from Rich Rubenstein, Kenneth Hobby, and the entire Cure SMA team: Cure SMA has had the honor to have Jessica Moyer and her […]
Read More ›FDA Engagement Update: The Voices of SMA
Thanks to our vibrant community, August was one of our largest and best awareness months ever, with unprecedented levels of public awareness and outreach for […]
Read More ›2015 SMA Researcher Meeting Summary: SMN Partners and Targets, Part 2
We will be posting a series of summaries from our 2015 researcher meeting, highlighting some of the most interesting new developments and discoveries presented there. […]
Read More ›2015 SMA Researcher Meeting Summary: SMN Partners and Targets, Part 1
We will be posting a series of summaries from our 2015 researcher meeting, highlighting some of the most interesting new developments and discoveries presented there. […]
Read More ›SMART Gives $50,000 to Cure SMA to Support Research
Based in Buffalo, NY, the Spinal Muscular Atrophy Research Team (SMART) is a grass roots organization started in 2009 to raise awareness and funds for […]
Read More ›Cure SMA and Isis Announce 2015 Holiday Card Contest
Back by popular demand, Cure SMA and Isis Pharmaceuticals are once again teaming up for a holiday card contest! This contest is open to children […]
Read More ›Family Registration for the 2016 Annual SMA Conference is Now Open
Registration is now open for the 2016 Annual SMA Conference, which will be held in Anaheim, CA, at The Disneyland Hotel from Thursday, June 16th […]
Read More ›Western New York Teen Wins Nickelodeon Halo Award
Fourteen-year-old Bailey Walter was recently selected from among 20,000 entrants to receive the August Nickelodeon Halo Effect Award. This award honors teens from around the […]
Read More ›New Update on Clinical Development of RG7800
Genentech recently provided an update on the clinical development of RG7800, an investigational SMN2 splicing modifier that is being studied as a potential treatment for […]
Read More ›